Praxis Precision Medicines, Inc.
Company Stats
- Market Cap
- $8.1B
- as of Sep 30, 2026
- Shares Outstanding
- 27.9M
- Free Float
- 61.4%
Income Statement
- Revenue
- $0
- Operating Income
- -$326.2M
- Net Income
- -$303.3M
- EBITDA
- -$326.1M
Cash Flow
- Free Cash Flow
- -$249.1M
- FCF Yield
- -3.1%
- Owner FCF Yield
- -3.5%
Balance Sheet
- Cash & Equivalents
- $357.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $0 | -$249.1M | — |
| FY2024 | $8.6M | -$131.8M | -1540.5% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 3, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges